XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Accumulated other Compressive Loss [Member]
Balances at beginning at Dec. 31, 2020 $ 45,547 $ 5 $ 227,987 $ (182,445)  
Balances at beginning (shares) at Dec. 31, 2020   5,307,713      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 1,095   1,095    
Issuance of restricted stock units under equity incentive plan (shares)   11,137      
Tax withholding payments for net share-settled equity awards (120)   (120)    
Tax withholding payments for net share-settled equity awards (shares)   (3,938)      
Net loss (8,954)     (8,954)  
Balances at ending at Mar. 31, 2021 37,568 $ 5 228,962 (191,399)  
Balances at end (shares) at Mar. 31, 2021   5,314,912      
Balances at beginning at Dec. 31, 2020 45,547 $ 5 227,987 (182,445)  
Balances at beginning (shares) at Dec. 31, 2020   5,307,713      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (28,082)        
Balances at ending at Sep. 30, 2021 20,203 $ 5 230,725 (210,527)  
Balances at end (shares) at Sep. 30, 2021   5,320,432      
Balances at beginning at Mar. 31, 2021 37,568 $ 5 228,962 (191,399)  
Balances at beginning (shares) at Mar. 31, 2021   5,314,912      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 857   857    
Issuance of restricted stock units under equity incentive plan (shares)   2,370      
Net loss (10,988)     (10,988)  
Balances at ending at Jun. 30, 2021 27,437 $ 5 229,819 (202,387)  
Balances at end (shares) at Jun. 30, 2021   5,317,282      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 906   906    
Issuance of restricted stock units under equity incentive plan (shares)   3,150      
Net loss (8,140)     (8,140)  
Balances at ending at Sep. 30, 2021 20,203 $ 5 230,725 (210,527)  
Balances at end (shares) at Sep. 30, 2021   5,320,432      
Balances at beginning at Dec. 31, 2021 17,793 $ 5 231,143 (213,355)  
Balances at beginning (shares) at Dec. 31, 2021   5,324,287      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 464   464    
Issuance of restricted stock units under equity incentive plan 180   180    
Issuance of restricted stock units under equity incentive plan (shares)   18,650      
Tax withholding payments for net share-settled equity awards (16)   (16)    
Tax withholding payments for net share-settled equity awards (shares)   (3,683)      
Sale of common stock\pre-funded warrants in public offering, net of costs 13,766 $ 3 13,763    
Sale of common stock\pre-funded warrants in public offering, net of costs (shares)   2,666,667      
Net loss (5,724)     (5,724)  
Foreign currency translation adjustment (2)       $ (2)
Balances at ending at Mar. 31, 2022 26,461 $ 8 245,534 (219,079) (2)
Balances at end (shares) at Mar. 31, 2022   8,005,921      
Balances at beginning at Dec. 31, 2021 17,793 $ 5 231,143 (213,355)  
Balances at beginning (shares) at Dec. 31, 2021   5,324,287      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (18,581)        
Foreign currency translation adjustment (2)        
Balances at ending at Sep. 30, 2022 15,200 $ 8 247,130 (231,936) (2)
Balances at end (shares) at Sep. 30, 2022   8,159,382      
Balances at beginning at Mar. 31, 2022 26,461 $ 8 245,534 (219,079) (2)
Balances at beginning (shares) at Mar. 31, 2022   8,005,921      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 571   571    
Net loss (6,725)     (6,725)  
Foreign currency translation adjustment 1       1
Balances at ending at Jun. 30, 2022 20,308 $ 8 246,105 (225,804) (1)
Balances at end (shares) at Jun. 30, 2022   8,005,921      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 683   683    
Sale of common stock\pre-funded warrants in public offering, net of costs 342   342    
Sale of common stock\pre-funded warrants in public offering, net of costs (shares)   104,773      
Exercise of common stock warrants   48,688      
Net loss (6,132)     (6,132)  
Foreign currency translation adjustment (1)       (1)
Balances at ending at Sep. 30, 2022 $ 15,200 $ 8 $ 247,130 $ (231,936) $ (2)
Balances at end (shares) at Sep. 30, 2022   8,159,382